{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T02:22:00Z","timestamp":1772677320358,"version":"3.50.1"},"reference-count":24,"publisher":"Informa UK Limited","issue":"5","license":[{"start":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T00:00:00Z","timestamp":1655424000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Wuhan Institute of Biological Products Co., Ltd"},{"name":"National Science and Technology","award":["2016ZX09101120-001-001"],"award-info":[{"award-number":["2016ZX09101120-001-001"]}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Human Vaccines & Immunotherapeutics"],"published-print":{"date-parts":[[2022,11,30]]},"DOI":"10.1080\/21645515.2022.2063630","type":"journal-article","created":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T19:03:57Z","timestamp":1655492637000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":2,"title":["Clinical evaluation of the lot-to-lot consistency of an enterovirus 71 vaccine in a commercial-scale phase IV clinical trial"],"prefix":"10.1080","volume":"18","author":[{"given":"Jinhua","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Research and Development, Wuhan Institute of Biological Products Co., Ltd, Wuhan, Hubei, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pengfei","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Vaccine Clinical Evaluation, Jiangsu Provincial Center of Disease Control and Prevention, Nanjing, Jiangsu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoqi","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Research and Development, Wuhan Institute of Biological Products Co., Ltd, Wuhan, Hubei, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qunying","family":"Mao","sequence":"additional","affiliation":[{"name":"Division of Hepatitis virus and Enterovirus Vaccine, National Institutes for Food and Drug Control, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fanyue","family":"Meng","sequence":"additional","affiliation":[{"name":"Department of Vaccine Clinical Evaluation, Jiangsu Provincial Center of Disease Control and Prevention, Nanjing, Jiangsu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinguo","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Research and Development, Wuhan Institute of Biological Products Co., Ltd, Wuhan, Hubei, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Research and Development, Wuhan Institute of Biological Products Co., Ltd, Wuhan, Hubei, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meizhi","family":"Du","sequence":"additional","affiliation":[{"name":"Department of Disease Prevention and Control, Pei County Center for Disease Control and Prevention, Pei County, Jiangsu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fan","family":"Gao","sequence":"additional","affiliation":[{"name":"Division of Hepatitis virus and Enterovirus Vaccine, National Institutes for Food and Drug Control, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei","family":"Liu","sequence":"additional","affiliation":[{"name":"School of Public Health, Southeast University, Nanjing, Jiangsu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiujuan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Disease Prevention and Control, Pei County Center for Disease Control and Prevention, Pei County, Jiangsu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changfu","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Research and Development, Wuhan Institute of Biological Products Co., Ltd, Wuhan, Hubei, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingbo","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Research and Development, Wuhan Institute of Biological Products Co., Ltd, Wuhan, Hubei, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiwei","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Research and Development, National Vaccine & Serum Institute, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingliang","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Research and Development, Wuhan Institute of Biological Products Co., Ltd, Wuhan, Hubei, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Research and Development, Wuhan Institute of Biological Products Co., Ltd, Wuhan, Hubei, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xing","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of Research and Development, Wuhan Institute of Biological Products Co., Ltd, Wuhan, Hubei, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Research and Development, Wuhan Institute of Biological Products Co., Ltd, Wuhan, Hubei, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongqiao","family":"Du","sequence":"additional","affiliation":[{"name":"Department of Research and Development, Wuhan Institute of Biological Products Co., Ltd, Wuhan, Hubei, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiuling","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Research and Development, Shanghai Institute of Biological Products Co., Ltd, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Duan","sequence":"additional","affiliation":[{"name":"Department of Research and Development, Wuhan Institute of Biological Products Co., Ltd, Wuhan, Hubei, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1644-0006","authenticated-orcid":false,"given":"Fengcai","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Vaccine Clinical Evaluation, Jiangsu Provincial Center of Disease Control and Prevention, Nanjing, Jiangsu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2022,6,17]]},"reference":[{"key":"e_1_3_5_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199909233411302"},{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph13090890"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.1827"},{"key":"e_1_3_5_5_1","unstructured":"WHO. Clinical considerations for evaluation of vaccines for prequalification. Points to consider for manufacturers of human vaccines; 2010 [accessed 2013 Set 12]. http:\/\/www.who.int\/immunization\/standards\/vaccine\/quality\/clinicalconsiderations\/oct10.pdf"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.4161\/hv.28397"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1586\/14760584.2016.1138862"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2021.1933451"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9030199"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)61049-1"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-14691-6_6"},{"key":"e_1_3_5_13_1","unstructured":"National Medical Products Administration. Guidelines for adverse event classification standards for clinical trials of preventive vaccines. [DC]. National Medical Products Administration December 31; 2019. Available from: http:\/\/english.nmpa.gov.cn\/2019-12\/31\/c_448385.htm"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61764-4"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.4161\/hv.19521"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2017.1335603"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1304923"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1303224"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2021.01.048"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.11847\/zgggws2017-33-07-03"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00491-13"},{"issue":"3","key":"e_1_3_5_22_1","first-page":"6","article-title":"Consistency of various batches of inactivated enterovirus 71 vaccine [J]","volume":"28","author":"Zhang Y","year":"2015","unstructured":"Zhang Y, Liu L, Dong C, et al. Consistency of various batches of inactivated enterovirus 71 vaccine [J]. Chin J Biol. 2015;28(3):6.","journal-title":"Chin J Biol"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2020.02.013"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0887-8994(98)00087-3"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(05)60789-1"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1586\/14760584.2015.993385"}],"container-title":["Human Vaccines & Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2022.2063630","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T21:02:34Z","timestamp":1707166954000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21645515.2022.2063630"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,17]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,11,30]]}},"alternative-id":["10.1080\/21645515.2022.2063630"],"URL":"https:\/\/doi.org\/10.1080\/21645515.2022.2063630","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"value":"2164-5515","type":"print"},{"value":"2164-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,17]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-02-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-04-05","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-17","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2063630"}}